Home > Term: milatuzumab
milatuzumab
A substance being studied in the treatment of multiple myeloma and several other types of cancer. It binds to CD74, a protein on the surface of myeloma cells and certain other types of cells. It may help kill cancer cells. Milatuzumab is a type of monoclonal antibody. Also called hLL1 and IMMU-110.
- Kalbos dalis: noun
- Pramonės šaka / sritis: Health care
- Category: Cancer treatment
- Company: U.S. HHS
0
Kūrėjas
- Lionel M
-
(Platinum) 5532 points - 100% positive feedback
